Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 11, Issue Suppl 2
782-I Phase I dose escalation of SAR445710, a PDL1-IL15 targeted cytokine in metastatic and/or advanced solid tumors
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular Abstracts – Part 2
Clinical Trial In Progress
782-I Phase I dose escalation of SAR445710, a PDL1-IL15 targeted cytokine in metastatic and/or advanced solid tumors
Online download statistics by month:
Online download statistics by month: December 2023 to June 2025
Abstract
Full
Pdf
Dec 2023
56
0
14
Jan 2024
50
0
6
Feb 2024
88
0
10
Mar 2024
100
0
7
Apr 2024
52
0
4
May 2024
98
0
12
Jun 2024
58
0
6
Jul 2024
82
0
9
Aug 2024
38
0
4
Sep 2024
44
0
14
Oct 2024
66
0
8
Nov 2024
58
0
5
Dec 2024
32
0
14
Jan 2025
40
0
8
Feb 2025
12
0
4
Mar 2025
2
0
5
Apr 2025
0
0
1
May 2025
0
0
6
Jun 2025
0
0
10
Total
876
0
147
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF